Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan. (March 2022) - Hashimoto, Takanao; Murayama, Anju; Mamada, Hanano; Saito, Hiroaki; Tanimoto, Tetsuya; Ozaki, Akihiko